Pivotal Bio Venture Partners Investment Advisor LLC Exscientia PLC Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $127 Million
- Q3 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Exscientia PLC stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 770,500 shares of EXAI stock, worth $3.73 Million. This represents 2.96% of its overall portfolio holdings.
Number of Shares
770,500
Previous 770,500
-0.0%
Holding current value
$3.73 Million
Previous $3.93 Million
4.3%
% of portfolio
2.96%
Previous 3.54%
Shares
2 transactions
Others Institutions Holding EXAI
# of Institutions
101Shares Held
33.5MCall Options Held
500Put Options Held
189K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$27.5 Million0.13% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY4.47MShares$21.6 Million0.3% of portfolio
-
Baillie Gifford & CO3.85MShares$18.6 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $593M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...